The environment for the conduct of clinical research in India is rapidly evolving and dynamic. Recent changes to regulatory policy are designed to create a more predictable, transparent and efficient process for the review of new India IND and NDA applications. The government is also looking to address research subject protection in a more holistic way.
These changes and other news out of India have left clinical trial Sponsors confused and anxious about India as a destination for their future studies. Therefore, Excel Life Sciences has designed a new complimentary webinar series to provide you with current, relevant and useful information on clinical research in India today.
Below is a description of the 1st webinar in the series, with links to the online registration form. There is no cost and no catch, but space is limited. Simply register and log into the webinar on the dates and times shown and we'll do the rest.
An Update on the Regulatory Environment for Clinical Research in India
Excel Life Sciences invites you and your colleagues to attend a complimentary 45 minute web-based seminar on the regulatory policy for new clinical trials in India. Lead by ELS executives with a combined 50+ years of clinical research and regulatory affairs experience in India, this short, hard-hitting session will provide you with a solid understanding of how to successfully navigate today's regulatory environment in India.
Specifically, the following topics will be addressed:
- Brief history of clinical research in India
- History of India's clinical research regulations
- Overview of recent regulatory changes
- Goals behind changes and ELS insights
- New structure of India regulatory agency
- New clinical trial submission/review process
- Current and anticipated review timelines
- Tips for correct submissions
- Review of potential risks, mistakes to avoid
- Questions and Answers
Please click on the link below to complete your complimentary registration.
or paste this link into your web browser:
Bonus Offer!
- The first 20 qualified registrants will receive a free study feasibility analysis in India, conducted by Excel Life Sciences.
- All attendees will receive a copy of the presentation materials, as well as two white papers related to clinical research in India.
Our system will send you an automatic confirmation of your registration and reminders leading up to the event:
No comments:
Post a Comment